Piramal to invest in Morpeth facility Illustrative image – not actual.

Piramal Healthcare will invest $11 million (approx Rs 70.29 crore) in its Morpeth facility, UK.


The company intends to triple its production capacity for hormonal products, including contraceptive pills and hormone replacement therapies. The production capacity of the unit will be increased by two billion tablets a year. The drug manufacturing plant will include formulation, package coating and tablet-making equipment. Expansion work will commence by December 2013 and the plant is scheduled to be operational in another 18 months.


The investment follows Piramal Healthcare's recent investment of $2.5 million (approx Rs 14.05 crore) in its FDA-approved Grangemouth site - also in the UK - to upgrade one of its antibody drug conjugate (ADC) manufacturing facilities.


 

← All latest storiesBack to top →